Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 2Neoplasms 1Colorectal Neoplasms 1COVID-19 1Advanced Pancreatic Cancer 1

Interventions

Gemcitabine 4130-nm albumin-bound paclitaxel 4Albumin-Bound Paclitaxel 2paricalcitol 1irinotecan sucrosofate 1gimeracil 1fluzoparib 1cabiralizumab 1Tegafur 1S 1 (combination) 1Oxaliplatin 1Nivolumab 1Leucovorin 1Irinotecan 1IMM-101 1Fluorouracil 1ADI PEG20 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Advanced Pancreatic Cancer × IMM-101 × Clear all
NCT01303172 2021-11-10

A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer

Immodulon Therapeutics Ltd

Phase 2 Completed
110 enrolled 14 charts
Gastrointestinal

Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡